Visual loss secondary to retinal ischemia is a serious and common clinical problem. It may occur as a result of acute vascular occlusion or of other ocular diseases whose pathogenetic mechanisms may involve retinal ischemia such as acute glaucoma, diabetic retinopathy and hypertensive vascular disease. Our long range goal is to enhance our understanding of the fundamental mechanisms responsible for ischemic retinal damage. Based upon the knowledge acquired, strategies to improve retinal viability in in vivo animal models resembling human disease will be developed. The pathophysiology of ischemic retinal damage is complex and appears to involve several mechanisms of cell death. Based upon our findings in the retina, as well as our findings in cerebral ischemia, we now propose to focus on the role of apoptotic cell death in retinal ischemia.
The specific aims of this project are to test the following hypotheses: 1) Apoptosis plays a role in the cascade of events leading to retinal degeneration following ischemia: a) In vivo ischemia followed by reperfusion induces apoptosis as determined by established morphologic (ultrastructural, cresyl violet), biochemical (DNA 'ladder') and immunohistochemical (TUNEL) parameters; b) Differential expression of apoptosis related genes accounts for the selective vulnerability of the inner retinal layers that occurs a result of transient ischemia. 2) Retinal ischemic injury may be prevented or attenuated by agents which inhibit apoptosis: a) Agents that inhibit apoptosis afford protection in an in vivo model of retinal ischemia; b) Overexpression of the bcl-2 gene product (a protein which inhibits apoptosis in a variety of other systems) results in less ischemic damage to the retina; c) Attenuation of the p53 gene product (a protein which promotes apoptosis in a variety of other systems) results in less ischemic damage to the retina. These hypothesis will be tested utilizing an in vivo model of transient retinal ischemia followed b reperfusion. Specific therapy for retinal ischemia may therefore be designed by obtaining a better understanding of basic mechanisms. The retina offers a unique situation, where these agents, all of which have significant systemic effects, may be utilized by injecting directly into the vitreous and thereby minimizing systemic effects. Utilized in this manner, agents that inhibit apoptosis or gene therapy that modifies the cells response to apoptosis may be exciting new approaches to the treatment of retinal ischemia.
| David, Joel; Melamud, Aleksandr; Kesner, Leo et al. (2011) A novel calpain inhibitor for treatment of transient retinal ischemia in the rat. Neuroreport 22:633-6 |
| Malhotra, Samit; Naggar, Isaac; Stewart, Mark et al. (2011) Neurogenic pathway mediated remote preconditioning protects the brain from transient focal ischemic injury. Brain Res 1386:184-90 |
| Rosenbaum, Daniel M; Degterev, Alexei; David, Joel et al. (2010) Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res 88:1569-76 |
| Dreixler, John C; Hemmert, Jonathan W; Shenoy, Shanti K et al. (2009) The role of Akt/protein kinase B subtypes in retinal ischemic preconditioning. Exp Eye Res 88:512-21 |
| Berger, Samuel; Savitz, Sean I; Nijhawan, Sheetal et al. (2008) Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 49:3605-10 |
| Jasmin, Jean-Francois; Malhotra, Samit; Singh Dhallu, Manjeet et al. (2007) Caveolin-1 deficiency increases cerebral ischemic injury. Circ Res 100:721-9 |
| Malhotra, Samit; Savitz, Sean I; Ocava, Lenore et al. (2006) Ischemic preconditioning is mediated by erythropoietin through PI-3 kinase signaling in an animal model of transient ischemic attack. J Neurosci Res 83:19-27 |
| Savitz, Sean I; Rosenbaum, Daniel M; Dinsmore, Jonathan H et al. (2002) Cell transplantation for stroke. Ann Neurol 52:266-75 |
| Zhang, Cheng; Rosenbaum, Daniel M; Shaikh, Afzhal R et al. (2002) Ischemic preconditioning attenuates apoptotic cell death in the rat retina. Invest Ophthalmol Vis Sci 43:3059-66 |
| Rosenbaum, D M; Rosenbaum, P S; Singh, M et al. (2001) Functional and morphologic comparison of two methods to produce transient retinal ischemia in the rat. J Neuroophthalmol 21:62-8 |
Showing the most recent 10 out of 16 publications
